Loading ...

A Phase 2a trial of Teplizumab and RN168 in patients with new onset type 1 diabetes mellitus

(

)

ITN Protocol #:

ITN083AI

Branded Name:

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Type 1 Diabetes

Current Status:

Withdrawn

Summary:

Study Personnel:

Protocol Chair

Kevan Herold, MDkevan.herold@yale.edu

Work: 

203-785-6507